Topical Treatment For Head Lice Therapeutics
1. Ulesfia patent expiration
Treatment: Topical treatment of lice infestations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5858383 | SHIONOGI INC | Methods and compositions for topical treatment of ectoparasites |
Aug, 2017
(8 years ago) | |
| US6139859 | SHIONOGI INC | Methods and compositions for topical treatment of ectoparasites |
Aug, 2017
(8 years ago) | |
| US6793931 | SHIONOGI INC | Ectoparasite asphyxiator compositions and methods for their applications |
Jul, 2022
(3 years ago) | |
| US7294342 | SHIONOGI INC | Ectoparasite asphyxiator compositions and methods for their application |
May, 2024
(1 year, 7 months ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Apr 09, 2014 |
Drugs and Companies using BENZYL ALCOHOL ingredient
NCE-1 date: 09 April, 2013
Market Authorisation Date: 09 April, 2009
Dosage: LOTION
How can I launch a generic of ULESFIA before it's drug patent expiration?
More Information on Dosage
ULESFIA family patents
